TargED receives NWO Take-Off 2
Congratulations to the team of our portfolio company TargED Biopharmaceuticals, as they have been awarded a Take-Off 2 grant from NWO (the Dutch National Science Organization)!
NEWS
TargED Biopharmaceuticals raises EUR 39 Million in Series A financing to bring groundbreaking thrombolytic treatment to patients22/02/2022 - 09:48
Utrecht Health Seed Fund’s first anniversary!03/09/2021 - 12:40
SentryX closes €3.2M seed funding round for the development of next generation pain relief therapeutics10/06/2021 - 09:54
